News and Trends 31 Jan 2017
New British Biotech-Academia Alliance takes on Cardiovascular Disease
Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for cardiovascular diseases. Heptares Therapeutics, based in London, develops drugs against historically undruggable G protein-coupled receptors…